echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Adcentrx Therapeutics announced the completion of a US$50 million Series A financing led by Cambridge Capital

    Adcentrx Therapeutics announced the completion of a US$50 million Series A financing led by Cambridge Capital

    • Last Update: 2021-07-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Adcentrx Therapeutics, a biotechnology company focused on the research and development of breakthrough antibody-conjugated drugs ("ADC"), announced the completion of a US$50 million Series A financing
    .


    The financing will accelerate Adcentrx's strategic layout in the ADC field and provide patients with more treatment options


    Adcentrx was founded by a senior team that has been deeply involved in ADC, target biology and pharmaceutical technology production for many years
    .


    The founder Dr.


    "We are very satisfied with the current development progress of the company's proprietary ADC platform and look forward to pushing a batch of innovative drugs into the development stage
    .


    " said Li Hui, founder and CEO of Adcentrx


    "Working with accomplished professionals in the ADC field makes us very excited
    .


    " Kangqiao Capital Managing Director Jiang Mengjiao said, "In addition to the current pipeline products, we are also very optimistic about the company's prospects for establishing a proprietary ADC platform.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.